Establishment of patient-derived non-small cell lung cancer xenograft models with genetic aberrations within EGFR, KRAS and FGFR1: useful tools for preclinical studies of targeted therapies

作者: Xu-chao Zhang , Jingchuan Zhang , Ming Li , Xiao-sui Huang , Xue-ning Yang

DOI: 10.1186/1479-5876-11-168

关键词:

摘要: … initial tumor regressions in lung cancer patients with EGFR … anti-tumor activity in lung cancer patients with KRAS mutation [32]. … profile in the patient-derived NSCLC models. Model L115 …

参考文章(37)
Theodora Voskoglou-Nomikos, Lesley Seymour, Joseph L. Pater, Clinical Predictive Value of the in Vitro Cell Line, Human Xenograft, and Mouse Allograft Preclinical Cancer Models Clinical Cancer Research. ,vol. 9, pp. 4227- 4239 ,(2003)
Bumsoo Park, Byong Chang Jeong, Yoon-La Choi, Ghee Young Kwon, Joung Eun Lim, Seong Il Seo, Seong Soo Jeon, Hyun Moo Lee, Han Yong Choi, Kyu-Sung Lee, Development and characterization of a bladder cancer xenograft model using patient-derived tumor tissue. Cancer Science. ,vol. 104, pp. 631- 638 ,(2013) , 10.1111/CAS.12123
Takafumi Kubo, Hiromasa Yamamoto, William W. Lockwood, Ilse Valencia, Junichi Soh, Michael Peyton, Masaru Jida, Hiroki Otani, Tetsuya Fujii, Mamoru Ouchida, Nagio Takigawa, Katsuyuki Kiura, Kenji Shimizu, Hiroshi Date, John D. Minna, Marileila Varella-Garcia, Wan L. Lam, Adi F. Gazdar, Shinichi Toyooka, MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors. International Journal of Cancer. ,vol. 124, pp. 1778- 1784 ,(2009) , 10.1002/IJC.24150
John J. Tentler, Aik Choon Tan, Colin D. Weekes, Antonio Jimeno, Stephen Leong, Todd M. Pitts, John J. Arcaroli, Wells A. Messersmith, S. Gail Eckhardt, Patient-derived tumour xenografts as models for oncology drug development Nature Reviews Clinical Oncology. ,vol. 9, pp. 338- 350 ,(2012) , 10.1038/NRCLINONC.2012.61
Edward A. Sausville, Angelika M. Burger, Contributions of Human Tumor Xenografts to Anticancer Drug Development Cancer Research. ,vol. 66, pp. 3351- 3354 ,(2006) , 10.1158/0008-5472.CAN-05-3627
Naz Chaudary, Melania Pintilie, Joerg Schwock, Neesha Dhani, Blaise Clarke, Michael Milosevic, Anthony Fyles, Richard P Hill, None, Characterization of the Tumor-Microenvironment in Patient-Derived Cervix Xenografts (OCICx) Cancers. ,vol. 4, pp. 821- 845 ,(2012) , 10.3390/CANCERS4030821
A M Dulak, C T Gubish, L P Stabile, C Henry, J M Siegfried, HGF-independent Potentiation of EGFR Action by c-Met Oncogene. ,vol. 30, pp. 3625- 3635 ,(2011) , 10.1038/ONC.2011.84
Diane Mathis, Christophe Benoist, A decade of AIRE. Nature Reviews Immunology. ,vol. 7, pp. 645- 650 ,(2007) , 10.1038/NRI2136
Teresa Troiani, Clorinda Schettino, Erika Martinelli, Floriana Morgillo, Giampaolo Tortora, Fortunato Ciardiello, The use of xenograft models for the selection of cancer treatments with the EGFR as an example. Critical Reviews in Oncology Hematology. ,vol. 65, pp. 200- 211 ,(2008) , 10.1016/J.CRITREVONC.2007.10.003
Ketao Jin, Lisong Teng, Yanping Shen, Kuifeng He, Zhenzhen Xu, Guangliang Li, Patient-derived human tumour tissue xenografts in immunodeficient mice: a systematic review Clinical and Translational Oncology. ,vol. 12, pp. 473- 480 ,(2010) , 10.1007/S12094-010-0540-6